The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours.
about
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancerTargeting DNA topoisomerase II in cancer chemotherapyPSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancerTopoisomerase levels determine chemotherapy responsein vitroandin vivosiRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer.Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.Proteomic changes resulting from gene copy number variations in cancer cellsERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 lossMaternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisQuantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.Potentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cellsOutcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A statusQuantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.Molecular markers of breast axillary lymph node metastasis.Integrated Proteomic and Transcriptomic-Based Approaches to Identifying Signature Biomarkers and Pathways for Elucidation of Daoy and UW228 Subtypes.Amplification of the BP1 homeobox gene in breast cancer.High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment.TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.Cutaneous metastatic breast carcinoma with clear cell features.Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
P2860
Q21144332-4F1DD8F5-710E-4FAE-B220-11F2806623BCQ24649711-18FDE413-0F24-469C-9457-A9C36D1F2AB9Q28267716-734D0DC6-DDE2-4E9F-8672-4CBC2DAFE17DQ29395563-DFF66061-D095-485B-BA8D-9128E8D68991Q31028906-83D8C501-106A-458E-8EA9-B714F2F25F3BQ33390513-60F9EA97-4B0B-431D-98F7-CF0F552BD4DBQ33413439-95C1DF34-1B8C-4BDF-AAD4-554D916B55A9Q33480671-388DFD07-3F04-457B-8513-999C5E1C8912Q33686899-B67620DF-47EB-42FD-BF93-A479C16A2DB9Q33878879-16F211E3-83FB-4ECA-90FE-83F21412E1E3Q34081938-548B6232-D4DD-436F-9EFF-54FF75D8AE49Q34493341-A06552B9-A5EE-431D-BC08-8EEB24478559Q35029573-8FC50F95-7A05-4937-BCBE-06B2A92F0A3CQ36244099-250FA9AF-CB2D-4CEC-A1B3-2E0EAE691C15Q37324977-8A45262D-DCCD-4449-A36B-02847028A7D7Q37376754-82B05ED7-A4D3-44E4-8DAF-1442ECE75D4EQ37542255-2C31199E-748D-49FA-A559-AFE5548616DBQ37728564-F6ADA6FD-E53F-422D-A1C4-5947F7C22F46Q39861648-583D76D1-FB14-4D39-B8B3-5D983DCD8725Q43055705-B2E7727F-4C15-41AA-935D-6CAB1E79E1C5Q48845796-31C6307A-106C-48C0-8BD3-6216F1BF3AABQ53107200-5BC2668F-A4C0-4398-9973-92AECFE98526Q54215084-CDAE513A-ECEE-4F18-B80B-9EFC3719C010Q54318735-47AB7EB3-23F5-4536-A092-48829DBC7A55Q54540314-1A16A84C-DF5A-4040-BABE-4A3EF9E7D745
P2860
The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The 17q12-q21 amplicon: Her2 a ...... the biology of solid tumours.
@ast
The 17q12-q21 amplicon: Her2 a ...... the biology of solid tumours.
@en
type
label
The 17q12-q21 amplicon: Her2 a ...... the biology of solid tumours.
@ast
The 17q12-q21 amplicon: Her2 a ...... the biology of solid tumours.
@en
prefLabel
The 17q12-q21 amplicon: Her2 a ...... the biology of solid tumours.
@ast
The 17q12-q21 amplicon: Her2 a ...... the biology of solid tumours.
@en
P2093
P1476
The 17q12-q21 amplicon: Her2 a ...... o the biology of solid tumours
@en
P2093
Daniela D Rosa
Gustavo F V Ismael
Max S Mano
Virginie Durbecq
P356
10.1016/J.CTRV.2006.10.001
P577
2006-11-17T00:00:00Z